New cell therapy tested for tough leukemia cases
NCT ID NCT06890494
Summary
This early-stage study is testing a new cell-based therapy called BiTE-EV for adults whose B-cell leukemia has returned or not responded to other treatments. The main goals are to check if the treatment is safe and to see if it helps control the cancer. A very small group of participants will receive the therapy every other day for one to two months and be closely monitored for side effects and response.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing GoBroad Hospital
RECRUITINGBeijing, China
Conditions
Explore the condition pages connected to this study.